Concepedia

Persistence To Therapy

Persistence to Therapy is a quantitative measure in medication adherence research that denotes the duration of time between the initiation and discontinuation of a prescribed treatment regimen, distinguishing itself from adherence by focusing on treatment continuation over time rather than the prescribed dosing schedule.

143

Publications

6.1K

Citations

899

Authors

440

Institutions

Publications per year

2017–2026

62

Variants

Treatment Persistence

Parents

Publications

143

The Impact of Monitoring on Adherence and Persistence with Antiresorptive Treatment for Postmenopausal Osteoporosis: A Randomized Controlled Trial

Jackie A. Clowes, Nicola Peel, Richard Eastell · The Journal of Clinical Endocrinology & Metabolism · 2004 · 334 citations · Full text

, , +17

Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice

Christopher R. Chapple, Jameel Nazir, Zalmaï Hakimi et al. · European Urology · 2017 · 202 citations · Full text

, , +17

Physician Follow-up and Provider Continuity Are Associated With Long-term Medication Adherence

M. Alan Brookhart · Archives of Internal Medicine · 2007 · 192 citations

, , +13

Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC

Anja Katholing, Christopher Wallenhorst, Carlos Martínez · Thrombosis and Haemostasis · 2015 · 171 citations

, , +17

Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin

Martin Zalesak, Kimberly Siu, Kevin Francis et al. · Circulation Cardiovascular Quality and Outcomes · 2013 · 150 citations

, , +17

1–5 of 143

Authors

899

  1. RB
    Russel Burge

    Eli Lilly (United States), United States

    4 publications · 71 citations

    4

    h-index

  2. MV
    Menno V. Huisman

    Leiden University Medical Center, Netherlands

    3 publications · 69 citations

    3

    h-index

  3. SM
    S. Mueller

    Wismar University of Applied Sciences, Germany

    3 publications · 145 citations

    3

    h-index

  4. GC
    Gabriel Chodick

    Tel Aviv University, Israel

    3 publications · 98 citations

    3

    h-index

  5. FD
    Francisco de Assis Acúrcio

    Universidade Federal de Minas Gerais, Brazil

    3 publications · 80 citations

    3

    h-index

1–5 of 899

Institutions

440

  1. Eli Lilly (United States)

    Indianapolis, United States

    7 h-index

    33 publications

    565 citations

  2. Truven Health Analytics (United States)

    Ann Arbor, United States

    4 h-index

    10 publications

    340 citations

  3. GlaxoSmithKline (United States)

    Philadelphia, United States

    4 h-index

    4 publications

    99 citations

  4. Novartis (United States)

    New York, United States

    4 h-index

    9 publications

    395 citations

  5. Amgen (United States)

    Thousand Oaks, United States

    4 h-index

    12 publications

    340 citations

  6. AbbVie (United States)

    North Chicago, United States

    3 h-index

    11 publications

    748 citations

  7. Boehringer Ingelheim (United States)

    Ridgefield, United States

    3 h-index

    13 publications

    1.7K citations

  8. Wake Forest University

    Winston-Salem, United States

    3 h-index

    6 publications

    92 citations

1–8 of 440

Venues

  1. PubMed

    Repository · 6 publications · 274 citations

    6

    h-index

  2. Patient Preference and Adherence

    4 publications · 79 citations

    4

    h-index

  3. British Journal of Clinical Pharmacology

    BJCP · 3 publications · 95 citations

    3

    h-index

  4. Current Medical Research and Opinion

    CMRO · 3 publications · 69 citations

    3

    h-index

  5. Diabetes Therapy

    3 publications · 190 citations

    3

    h-index

1–5